81 related articles for article (PubMed ID: 8560842)
1. [Sensitivity of atherosclerosis indices in patients with ischemic brain disease].
Marić D; Ivanisević V; Ilić T; Jović P
Vojnosanit Pregl; 1994; 51(4):271-6. PubMed ID: 8560842
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinogen and lipids: associated risk factors for ischemic cerebral stroke].
Honczarenko K; Torbus-Lisiecka B; Osuch Z; Nocoń D; Nowacki P; Potemkowski A; Narolewska A
Neurol Neurochir Pol; 1999; 33(3):557-65. PubMed ID: 10540718
[TBL] [Abstract][Full Text] [Related]
3. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
5. [Serum apolipoproteins A1, B and Apo A1/Apo B index in children with advanced chronic renal failure and on dialysis].
Puziewicz-Zmonarska A; Zwolińska D; Makulska I; Zmonarski SC
Pol Merkur Lekarski; 2003 Apr; 14(82):299-303. PubMed ID: 12868188
[TBL] [Abstract][Full Text] [Related]
6. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
Bugugnani MJ; Haiat R; Fouyé H; Rémy A; Desoutter P
Ann Biol Clin (Paris); 1981; 39(3):131-4. PubMed ID: 6787958
[TBL] [Abstract][Full Text] [Related]
7. [The changes of lipids, lipoproteins and apolipoproteins in plasma in ischemic stroke].
Barkhatova VP; Suslina ZA; Ionova VG; Chudakova IA; Mel'kina OE; Tanashian MM; Rebrova OIu
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(8):34-8. PubMed ID: 9752680
[TBL] [Abstract][Full Text] [Related]
8. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
Kostner GM; Marth E; Pfeiffer KH; Wege H
Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
[No Abstract] [Full Text] [Related]
9. Plasma level of atherogenic and anti-atherogenic factors among palm wine drinkers of rural southwest Nigeria.
Ogunro PS; Ologunagba PO
Afr J Med Med Sci; 2012 Dec; 41(4):337-47. PubMed ID: 23672097
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes and low density lipoproteins--a molecular complex or the summation of the atherogenic risk of two separate entities?
Serban MG; Niţă V
Rom J Intern Med; 1993; 31(3):193-8. PubMed ID: 8130757
[TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins as markers and managers of coronary risk.
Chan DC; Watts GF
QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
[TBL] [Abstract][Full Text] [Related]
12. [Association of risk factors for cerebral atherosclerosis in patients with acute ischemic brain disease].
Raicević ; Jovicić A; Veljancić D; Djordjević D; Cedić V; Dindić E; Jović P
Vojnosanit Pregl; 1998; 55(3):255-63. PubMed ID: 9720440
[TBL] [Abstract][Full Text] [Related]
13. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
Cabezas Castro M; Liem A
Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic stroke.
Lei C; Wu B; Liu M; Chen Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1112-7. PubMed ID: 24189455
[TBL] [Abstract][Full Text] [Related]
15. Plasma adrenomedullin in cerebrovascular disease: a possible indicator of endothelial injury.
Kuwasako K; Kida O; Kitamura K; Kato J; Eto T
Int Angiol; 1997 Dec; 16(4):272-9. PubMed ID: 9543227
[TBL] [Abstract][Full Text] [Related]
16. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
Ballantyne CM; Pitt B; Loscalzo J; Cain VA; Raichlen JS
Am J Cardiol; 2013 Feb; 111(4):506-9. PubMed ID: 23237107
[TBL] [Abstract][Full Text] [Related]
17. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
[TBL] [Abstract][Full Text] [Related]
18. Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study.
van Schouwenburg IM; Mahmoodi BK; Gansevoort RT; Muntinghe FL; Dullaart RP; Kluin-Nelemans HC; Veeger NJ; Meijer K
Thromb Haemost; 2012 Nov; 108(5):923-9. PubMed ID: 22955992
[TBL] [Abstract][Full Text] [Related]
19. Different impact of hyperhomocysteinemia on cerebral small vessel ischemia and cervico-cerebral atherosclerosis in non-stroke individuals.
Park SY; An SA; Lee HB; Kim Y; Kim NK; Kim SH; Kim OJ; Oh SH
Thromb Res; 2013 Jan; 131(1):e12-6. PubMed ID: 23218488
[TBL] [Abstract][Full Text] [Related]
20. The role of plasma lipids in carotid bifurcation atherosclerosis.
Ford CS; Crouse JR; Howard G; Toole JF; Ball MR; Frye J
Ann Neurol; 1985 Mar; 17(3):301-3. PubMed ID: 3994317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
